SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities
SEC Accession No. 0000947871-11-001001
Filing Date
2011-12-13
Accepted
2011-12-13 18:37:17
Documents
1
Period of Report
2011-12-09
Filing Date Changed
2011-12-13

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT ss133891_4.html 4  
1 OWNERSHIP DOCUMENT ss133891_4.xml 4 8670
  Complete submission text file 0000947871-11-001001.txt   10978
Mailing Address
Business Address
ISALY SAMUEL D (Reporting) CIK: 0001055949 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34637 | Film No.: 111259553

Mailing Address 767 3RD AVENUE 30TH FLOOR NEW YORK NY 10017
Business Address 767 3RD AVENUE 30TH FLOOR NEW YORK NY 10017 2126845700
ORBIMED ADVISORS LLC (Reporting) CIK: 0001055951 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 001-34637 | Film No.: 111259555

Mailing Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545
Business Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545 (510) 856-5600
Anthera Pharmaceuticals Inc (Issuer) CIK: 0001316175 (see all company filings)

IRS No.: 201852016 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address 767 THIRD AVENUE, 30TH FLOOR NEW YORK NY 10017
Business Address 767 THIRD AVENUE, 30TH FLOOR NEW YORK NY 10017 212-739-6400
OrbiMed Capital GP IV LLC (Reporting) CIK: 0001502240 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-34637 | Film No.: 111259554